• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Essilor names new VP, brings French art to Dallas

Article

Dallas-Essilor of America has named Carl Bracy as vice president of marketing. Bracy, who previously was senior vice president of retail markets for TXU Corp., a Dallas energy company, will be responsible for introducing Essilor products and services to the marketplace.

Dallas-Essilor of America has named Carl Bracy as vice president of marketing. Bracy, who previously was senior vice president of retail markets for TXU Corp., a Dallas energy company, will be responsible for introducing Essilor products and services to the marketplace.

Meanwhile, the company is bringing to its local headquarters a taste of its France-based parent company.

Essilor of America is sponsoring an exhibition of 70 iconic works by the masters of French 19th century art at the Dallas Museum of Art. The show, called "Bonjour, Monsieur Courbet! The Bruyas Collection of the Musee Fabre, Montpellier," will be on display through early January.

"The viewing of the paintings, drawings, and sculptures from this beautiful period is a subtle reminder as to why our company's mission is all about vision," said Hubert Sagnieres, president of Essilor of America.

Related Videos
Video 1 - "Challenging the Definition of Dry Eye- Interpreting Diagnostic Tests"
ASCRS 2024: ViaLase Updates on Nonincisional Glaucoma Treatment Targeting Trabecular Meshwork
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.